Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash $ 1,239 $ 500
Accounts receivable 756
Inventory 587,847 588,110
Total current assets 589,842 588,610
Equipment, net 2,765 3,110
Intangible assets, net 40,970 50,425
Total assets 633,577 642,145
Current liabilities:    
Accounts payable 26,604 10,483
Due to related party 1,198,998 1,165,171
Short term notes payable, less unamortized debt issuance cost of $0 and $0 at March 31, 2020 and December 31, 2019 respectively 98,187 98,187
Convertible notes payable 1,796,524 1,801,524
Other current liabilities 82,732 27,450
Total current liabilities 3,203,045 3,102,815
Total liabilities 3,203,045 3,102,815
Commitment and contingencies
Shareholders' deficit    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 1 and 1 share issued and outstanding at March 31, 2020 and December 31, 2019 respectively
Common stock, $0.0001 par value, 150,000,000 shares authorized; 95,772,408 and 92,439,074 shares issued and outstanding at March 31, 2020 respectively, and 81,272,408 shares issued and outstanding at December 31, 2019 9,244 8,128
Additional paid-in-capital 13,650,461 13,607,161
Accumulated deficit (16,229,173) (16,075,959)
Total stockholders' deficit (2,569,468) (2,460,670)
Total liabilities and stockholders' deficit $ 633,577 $ 642,145